Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Two Cardiovascular Trial Hits Get Merck & Co.’s Blood Pumping

Sotatercept And MK-0616 Both Blockbuster-Tipped

08 Mar 2023

• By Andrew McConaghie

Merck

Related Content

Buy-And-Bill A Bust For Novartis's Leqvio?

03 Jan 2023

Merck & Co.’s Big Ambition To ‘Democratize’ PCSK9s

07 Mar 2023

Merck’s Sotatercept Hits Phase III Marks In Mid-Stage PAH Patients

10 Oct 2022

Merck & Co Maps Out Route To $10bn Cardiovascular Franchise

06 Apr 2022

Related Companies

Merck & Co., Inc.

United Therapeutics Corporation

Keros Therapeutics

Acceleron Pharma, Inc.

Novartis AG

Additional Topics

Clinical Trials Business Strategies Research & Development Strategy Cardiovascular BioPharmaceutical

More from Cardiovascular

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.